- Report
- April 2026
- 196 Pages
Global
From €5165EUR$5,850USD£4,486GBP
- Report
- April 2026
- 139 Pages
Global
From €5165EUR$5,850USD£4,486GBP
- Report
- April 2026
- 299 Pages
Global
From €5165EUR$5,850USD£4,486GBP
- Report
- April 2026
- 413 Pages
Global
From €5165EUR$5,850USD£4,486GBP
- Report
- April 2026
- 293 Pages
Global
From €5165EUR$5,850USD£4,486GBP
- Report
- February 2026
- 250 Pages
Global
From €3964EUR$4,490USD£3,443GBP
- Report
- February 2026
- 250 Pages
Global
From €3964EUR$4,490USD£3,443GBP
- Report
- January 2026
- 180 Pages
Global
From €3973EUR$4,500USD£3,451GBP
- Report
- August 2025
- 188 Pages
Global
From €3973EUR$4,500USD£3,451GBP
- Report
- November 2025
- 200 Pages
Global
From €7019EUR$7,950USD£6,097GBP
- Report
- November 2025
- 200 Pages
Global
From €7019EUR$7,950USD£6,097GBP
- Report
- November 2025
- 200 Pages
Global
From €7019EUR$7,950USD£6,097GBP
- Clinical Trials
- July 2025
- 60 Pages
Global
From €1324EUR$1,500USD£1,150GBP
- Report
- March 2026
- 200 Pages
Global
From €2462EUR$2,789USD£2,139GBP
- Report
- July 2025
- 350 Pages
Global
From €4369EUR$4,949USD£3,795GBP
- Report
- June 2025
- 200 Pages
Global
From €2462EUR$2,789USD£2,139GBP
- Report
- June 2025
- 200 Pages
Global
From €2462EUR$2,789USD£2,139GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2462EUR$2,789USD£2,139GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2462EUR$2,789USD£2,139GBP
- Report
- June 2025
- 400 Pages
Global
From €4369EUR$4,949USD£3,795GBP

Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon.
CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs.
The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more